Neurology:伴沟底发育不良的癫痫双侧结构网络异常

2021-10-29 Naomii MedSci原创

研究证明了双边分布的、特定的白质网络在BOSD中易受干扰的证据。纤维束异常的程度部分与癫痫发作活动有关,但其他因素,如遗传背景和治疗或环境的影响并未被排除在外。

     目前,局灶性癫痫被广泛认为是一种网络障碍;据此,局灶性病变可以导致脑部网络的广泛异常。这些癫痫的网络概念化主要是由颞叶癫痫的证据驱动的;然而,最近的研究表明,局灶性皮质发育不良(FCD)的特征也可能是广泛的功能网络异常。目前尚不清楚FCD中是否有特定的结构网络容易受到破坏,探索全网络破坏的努力在一定程度上受到了阻碍。

     沟底发育不良(BOSD)是一种FCD,具有独特的神经病理和神经影像学特征。考虑到手术后的良好结果,BOSD病变被认为是固有的癫痫样病变,被认为是局灶性异常,而不是弥漫性病变。然而,与其他形式的局灶性癫痫一样,BOSD可能与更广泛的脑组织破坏有关。然而,目前尚不清楚BOSD是否以特定大脑网络中断为特征,如果是的话,哪些结构网络受到影响。

     近日,有研究人员应用了一种被称为基于固定的分析(FBA)的技术,该技术能够识别特定的白质结构,这些白质结构表现出临床上重要的结构连通性降低,从而鉴定脑沟底发育不良(BOSD)患者脑白质纤维束的结构异常,并探讨其与癫痫发作活动的关系。

     对弥散磁共振成像数据进行了基于全脑固定的分析,以确定与健康对照组参与者(n=40)相比,BOSD患者(n=20)的白质纤维束的纤维密度和横截面显著降低。以全脑分析结果为先验,探讨纤维束异常与癫痫发作频率和持续时间的关系。

  • 尽管异常增生是局灶性的,但BOSD患者表现出广泛的白质纤维束异常,包括双侧皮质脊髓、皮质丘脑和小丘脑束、上纵束、胼胝体(体)和胼胝体辐射线枕部。这种双侧连通性降低的模式与病变的偏侧性无关。
  • 事后探索性分析显示,高癫痫发作频率与钳子主束、双侧皮质脊髓束和小丘脑束纤维密度降低程度更大相关。

      研究证明了双边分布的、特定的白质网络在BOSD中易受干扰的证据。纤维束异常的程度部分与癫痫发作活动有关,但其他因素,如遗传背景和治疗或环境的影响并未被排除在外。

文献来源:Mito R, Vaughan DN, Semmelroch M, Connelly A, Jackson GD. Bilateral Structural Network Abnormalities in Epilepsy Associated With Bottom-of-Sulcus Dysplasia [published online ahead of print, 2021 Oct 21]. Neurology. 2021;10.1212/WNL.0000000000013006. doi:10.1212/WNL.0000000000013006

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2001571, encodeId=1f3d20015e110, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Nov 09 23:46:21 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1347585, encodeId=f046134e5858c, content=<a href='/topic/show?id=88713e938c1' target=_blank style='color:#2F92EE;'>#发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37938, encryptionId=88713e938c1, topicName=发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4c124, createdName=neurowu, createdTime=Sat Oct 30 12:46:21 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522485, encodeId=c58b15224855f, content=<a href='/topic/show?id=46223e39897' target=_blank style='color:#2F92EE;'>#双侧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37398, encryptionId=46223e39897, topicName=双侧)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=741b11453403, createdName=wangbingxhy, createdTime=Sat Oct 30 12:46:21 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568014, encodeId=8e7b1568014c6, content=<a href='/topic/show?id=7a833e94079' target=_blank style='color:#2F92EE;'>#发育不良#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37940, encryptionId=7a833e94079, topicName=发育不良)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30b515313716, createdName=villahu, createdTime=Sat Oct 30 12:46:21 CST 2021, time=2021-10-30, status=1, ipAttribution=)]
    2021-11-09 yinhl1978
  2. [GetPortalCommentsPageByObjectIdResponse(id=2001571, encodeId=1f3d20015e110, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Nov 09 23:46:21 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1347585, encodeId=f046134e5858c, content=<a href='/topic/show?id=88713e938c1' target=_blank style='color:#2F92EE;'>#发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37938, encryptionId=88713e938c1, topicName=发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4c124, createdName=neurowu, createdTime=Sat Oct 30 12:46:21 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522485, encodeId=c58b15224855f, content=<a href='/topic/show?id=46223e39897' target=_blank style='color:#2F92EE;'>#双侧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37398, encryptionId=46223e39897, topicName=双侧)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=741b11453403, createdName=wangbingxhy, createdTime=Sat Oct 30 12:46:21 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568014, encodeId=8e7b1568014c6, content=<a href='/topic/show?id=7a833e94079' target=_blank style='color:#2F92EE;'>#发育不良#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37940, encryptionId=7a833e94079, topicName=发育不良)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30b515313716, createdName=villahu, createdTime=Sat Oct 30 12:46:21 CST 2021, time=2021-10-30, status=1, ipAttribution=)]
    2021-10-30 neurowu
  3. [GetPortalCommentsPageByObjectIdResponse(id=2001571, encodeId=1f3d20015e110, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Nov 09 23:46:21 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1347585, encodeId=f046134e5858c, content=<a href='/topic/show?id=88713e938c1' target=_blank style='color:#2F92EE;'>#发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37938, encryptionId=88713e938c1, topicName=发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4c124, createdName=neurowu, createdTime=Sat Oct 30 12:46:21 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522485, encodeId=c58b15224855f, content=<a href='/topic/show?id=46223e39897' target=_blank style='color:#2F92EE;'>#双侧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37398, encryptionId=46223e39897, topicName=双侧)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=741b11453403, createdName=wangbingxhy, createdTime=Sat Oct 30 12:46:21 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568014, encodeId=8e7b1568014c6, content=<a href='/topic/show?id=7a833e94079' target=_blank style='color:#2F92EE;'>#发育不良#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37940, encryptionId=7a833e94079, topicName=发育不良)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30b515313716, createdName=villahu, createdTime=Sat Oct 30 12:46:21 CST 2021, time=2021-10-30, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2001571, encodeId=1f3d20015e110, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Nov 09 23:46:21 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1347585, encodeId=f046134e5858c, content=<a href='/topic/show?id=88713e938c1' target=_blank style='color:#2F92EE;'>#发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37938, encryptionId=88713e938c1, topicName=发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4c124, createdName=neurowu, createdTime=Sat Oct 30 12:46:21 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522485, encodeId=c58b15224855f, content=<a href='/topic/show?id=46223e39897' target=_blank style='color:#2F92EE;'>#双侧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37398, encryptionId=46223e39897, topicName=双侧)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=741b11453403, createdName=wangbingxhy, createdTime=Sat Oct 30 12:46:21 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568014, encodeId=8e7b1568014c6, content=<a href='/topic/show?id=7a833e94079' target=_blank style='color:#2F92EE;'>#发育不良#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37940, encryptionId=7a833e94079, topicName=发育不良)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30b515313716, createdName=villahu, createdTime=Sat Oct 30 12:46:21 CST 2021, time=2021-10-30, status=1, ipAttribution=)]

相关资讯

BMJ:未破裂大脑中动脉瘤所导致的局灶性癫痫

女性患者,60岁,患有偏头痛和高血压。近日出现渐进性记忆障碍和间歇性的嗅觉幻觉,诊断为颞叶癫痫。磁共振成像(如下所示)和脑磁共振血管造影显示,患者右侧大脑存在未破裂的14 mm大小的中动脉瘤,压迫了右侧颞叶皮层。这或是导致患者症状出现的原因。患者最终将接受外科治疗。局灶性癫痫是未破裂脑动脉瘤的一种罕见的表现,尤其是那些与颞叶内侧接触的脑动脉瘤。治疗方法包括手术夹闭动脉瘤和血管内栓塞术,两者都或可导

JAMA Neurol:局灶性癫痫不同发作周期的发生率

局灶性癫痫的特征是周期性发作

Lancet:左乙拉西坦 vs 左尼沙胺 vs拉莫三嗪一线治疗新诊断的局灶性癫痫

对于新诊断的局灶性癫痫患者,左乙拉西坦或左尼沙胺单药治疗的效果及成本效益均劣于拉莫三嗪,拉莫三嗪仍应是局灶性癫痫患者的一线治疗药物

Lancet Neurol:Cenobamate治疗不受控制的局灶性癫痫

研究发现,Cenobamate可减少局灶性(部分)发作癫痫发作频率。在最高剂量组中,治疗引起的不良事件最为常见。对于不受控制的局灶性癫痫患者,Cenobamate似乎是一种有效的治疗选择

UCB癫痫药物Brivarcetam III期显著改善癫痫发作

比利时制药巨头优时比(UCB)7月23日公布了癫痫药物brivaracetam(布瓦西坦)一项为期12周的III期研究的积极顶线数据。该项研究在768例伴有部分性发作(POS)但经1种或2种抗癫痫药物(AED)联合用药不能完全控制病情的局灶性癫痫(focal epilepsy)成人患者中开展,调查了brivaracetam(100和200mg/天)相对于安慰剂的疗效和安全性,研究中,将briv

Neurology:MRI对局灶性癫痫的致痫病灶检出率较高

MRI对癫痫的诊断及治疗的作用越来越受到重视,来自澳大利亚的Tahir Hakami等研究者评价了MRI对癫痫的诊断价值,确定了脑MRI对新发癫痫的病原灶的诊断检出率及病灶的特征,研究结果发表在2013年9月3日的Neurology杂志上。 该研究为前瞻性研究,在10年期间内连续随机纳入了993例癫痫发作患者,其中597例为男性,平均年龄为42.2岁。颅脑MRI使用3及1.5特斯拉,分析其诊断癫

拓展阅读

PN:拉考沙胺对儿童局灶性癫痫发作间期癫痫样放电的影响

LCM对IEDs数量的影响可能与癫痫发作结局无关。

2023年美国神经病学学会新兴科学年会: NRTX-1001 GABA能中间神经元细胞治疗局灶性癫痫的首次人体试验

NRTX-1001 GABA能中间神经元治疗局灶性癫痫的首次人体研究正在进行中,初步结果令人鼓舞。

Neurology:难治性局灶性癫痫患者辅助性塞诺巴胺的长期疗效和安全性研究

在CNB治疗的48个月中,长期疗效,包括100%和≥90%的癫痫发作减少,在24个月中保持了71%的疗效。

Neurology:MRI对局灶性癫痫发作的致痫病灶检出率较高

MRI可在新诊断的癫痫患者部分患者中发现致痫病灶,其中部分性发作的患者出现的比例较高。MRI发现致痫病灶与出现异常脑电图并不相关。

Lancet:左乙拉西坦 vs 左尼沙胺 vs拉莫三嗪一线治疗新诊断的局灶性癫痫

对于新诊断的局灶性癫痫患者,左乙拉西坦或左尼沙胺单药治疗的效果及成本效益均劣于拉莫三嗪,拉莫三嗪仍应是局灶性癫痫患者的一线治疗药物

JAMA Neurol:局灶性癫痫不同发作周期的发生率

局灶性癫痫的特征是周期性发作